Tag Archives: biotech

Stem Cells, Cell and Gene Therapy Biotechs to Discuss Capital Formation Strategies and Validation

NEW YORK – In a progressive cell therapy environment that has decreasing clinical attrition, next generation and next-to-launch biotechs along with regulators, will be talking about current strategies and approaches to advance the development of stem cells, cell and gene therapies.

Over 250 biotechs, biopharma, research institutions and regulators will gather at the Stem Cells USA & Regenerative Medicine Congress on September 30 – October 1, 2013.